Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
the Treatment
.
Show all posts
Showing posts with label
the Treatment
.
Show all posts
Saturday, July 11, 2026
FDA Approves Bysanti (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia
›
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Bysanti (milsaperido...
Tuesday, July 7, 2026
FDA Approves Icotyde (icotrokinra) for the Treatment of Plaque Psoriasis
›
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an in...
›
Home
View web version
